TABLE 2: Comparison of CXCL9, CXCL10, CXCL11, CXCR3 levels between patients with moderate and severe COVID-19 and healthy controls.

Parameter	Moderate disease Mean [SD]	Severe disease Mean [SD]	Healthy controls average [SD]	p
	n=30	n=41	n=35
CXCL9 (pg/mL)	704.55 [471.14]	940.09 [498.83]	194.64 [88.13]	<0.043 a <0.001 b,c
CXCL10 (pg/mL)	159.62 [43.63]	288.66 [102.71]	71.01 [39.77]	<0.001 a,b,c
CXCL11 (pg/mL)	139.64 [67.58]	290.52 [60.23]	93.49 [54.29]	<0.001 a,b <0.008 c
CXCR3 (pg/mL)	559.38 [234.64]	896.85 [326.77]	163.48 [52.30]	<0.001 a,b,c

Note: Statistically significant results are indicated in bold. ^a Patients with moderate vs. severe COVID-19; ^b Patients with severe COVID-19 vs. controls; ^c Patients with moderate COVID-19 vs. controls.